![logo](/logos/AXNX.webp)
Axonics, Inc.
NASDAQ:AXNX
68.83 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Axonics, Inc. |
Symbool | AXNX |
Munteenheid | USD |
Prijs | 68.83 |
Beurswaarde | 3,518,458,823 |
Dividendpercentage | 0% |
52-weken bereik | 48.3 - 69.68 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Raymond W. Cohen |
Website | https://www.axonics.com |
An error occurred while fetching data.
Over Axonics, Inc.
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)